execs Ubisoft

Ubisoft Execs Resign Following Sexual Harrasment Allegations – Push Square

Hascoet, Cornet, and Mallat gone

Ubisoft Logo

Update: The publisher has now issued a statement ahead of Ubisoft Forward this evening:

Original story: Members of Ubisoft’s executive team have resigned from the company after multiple allegations of sexual harassment were made against them. The chief creative officer, named Serge Hascoet, human resources director Cecile Cornet, and Yannis Mallat have all left the French publisher. The latter was the managing director of Ubisoft’s Canadian branch, who said: “The recent allegations that have come to light in Canada against multiple employees make it impossible for [Mallat] to continue in this position.”

Bloomberg’s Jason Schreier expanded on what this means for the company after more than 100 cases of sexual harassment were made to Ubisoft’s HR division. “Serge Hascoet was the man in charge of ALL of their games. With one word he could greenlight or cancel a project. Many Ubisoft employees believed he was too powerful and close to the CEO to ever be ousted, no matter how many allegations emerged”, he said on Twitter. Yves Guillemot has said that the editorial team will receive a complete overhaul in an effort to create an inclusive and open culture.

Ubisoft plans to host its Forward digital event in just a matter of hours. However, due to its pre-taped nature, it is unlikely that the publisher will comment on the current situation.

[source, via]

Read More

execs Modern

Modern execs sell stock amid coronavirus vaccine news – New York Daily News

New York Daily News

May 22, 2020 11:57 PM

This is the Moderna, Inc., building in Cambridge, Mass. (AP Photo/Bill Sikes)

This is the Moderna, Inc., building in Cambridge, Mass. (AP Photo/Bill Sikes)(Bill Sikes/AP)

Top Moderna executives dumped almost $30 million in shares early this week as the company’s stock value climbed after positive results from its coronavirus vaccine trials, CNN reported.

The sales raised eyebrows, but the Massachusetts drug company said the transactions were executed in accordance with plans outlined in advance, according to CNN.

Moderna stock ended the week closer to where it started. Giddy investors flocked to the Massachusetts drug company after it said that participants in a study of its COVID-19 vaccine were developing antibodies.

Charles Whitehead, a professor at Cornell Law School whose focus includes business transactions, told CNN, “On its face, there is nothing wrong with these trades.”

Moderna CEO Stéphane Bancel also netted $1.2 million on Wednesday selling shares, according to CBS News.

Recommended on Daily News

Most Read • Coronavirus

Read More

execs owners

NBA owners, execs hopeful for return after call with Adam Silver, sources say – ESPN

9:57 PM ET

  • Adrian WojnarowskiSenior NBA Insider


    • Host of The Woj Pod
    • Joined ESPN in 2017

Participants on a board of governors call on Tuesday with NBA commissioner Adam Silver left the virtual meeting feeling increasingly positive about the league’s momentum toward a resumption of play this season, sources told ESPN.

Owners and executives on the call were encouraged about the league’s progress toward minimizing health risk upon a return and the league office’s positive conversations with the National Basketball Players Association about the players’ desire to eventually restart the season, sources said.

Discussions centered on health and safety concerns, including the goal of getting team officials and players comfortable with the idea that a positive test for the coronavirus upon a return would not shutter play.

Silver told those on the call that if a positive test would “shut us down, we probably shouldn’t go down this path.”

The question remains: How many positive tests would be too many? That is among the questions that the NBA, NBPA and medical experts have to come to terms with in the coming weeks before the league and union can greenlight a resumption of play.

Once the NBA formalizes a return to play, the league indicated to teams that the plan would be to standardize coronavirus testing among the 30 teams, sources said. For now, the NBA is allowing teams to use a variety of tests.

As for the format in a return to play, there still is no decision on the kind of form that would take with the 30 NBA teams, sources said. The league hasn’t worked through the details on whether all 30 teams would return or whether regular-season games would be played or if perhaps there would be a play-in tournament to give more teams a chance to make the 16-team playoff field, sources said.

When asked about the bubble-isolation plan on the call, Silver described it as a “campus environment,” sources said. He has talked about one or two locations for players, and the focus continues to be on Orlando’s Walt Disney World Resort and Las Vegas, sources said.

The NBA shared with owners several factors that it plans to study over the next two to four weeks before deciding on restarting the league.

Among them, sources said: Understanding the trajectory of new cases in those states starting to reopen, understanding who is getting severely ill and why, and developments in testing types. The NBA also is studying how other leagues are handling positive tests among participants, sources said.

On the call, the league office wasn’t optimistic about rapid-response testing becoming widely available within the next month, sources said.

There was growing confidence among owners on the call about how players were responding to the return to practice facilities. The league believes it will have 22 of its 30 facilities open by Monday, sources said.

The league office described to owners how leagues in the United States — and across the world — are handling a return to play, especially detailing overseas leagues, from the Premier League to La Liga to the Chinese Basketball Association, sources said.

Read More